RxDoctor Payments Data

Emily Amburn, PA

Physician Assistant · Knoxville, TNNPI 1942834494

Payments from drug & device makers

$3,016in general payments, 2019–2025

Across 152 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$464
  • AstraZeneca$405
  • Amarin Pharma, Inc.$351
  • Johnson & Johnson$344
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$258
  • Novartis$254
  • plus $940 from 13 others

What the payments were for

  • Food & beverage$3,016100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,016 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$33,661
Medicare patients
235
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban374$278,997
JardianceEmpagliflozin96$65,556
XareltoRivaroxaban52$60,862
EntrestoSacubitril/Valsartan56$47,172
FarxigaDapagliflozin Propanediol48$39,706
BrilintaTicagrelor53$30,270
Repatha SureclickEvolocumab31$22,911
Repatha SyringeEvolocumab14$11,215
NexletolBempedoic Acid14$5,642
Ranolazine ErRanolazine57$4,009
Metoprolol Succinate311$3,669
Atorvastatin Calcium290$2,621
Rosuvastatin Calcium117$2,020
Diltiazem 24hr Er (Cd)Diltiazem Hcl99$1,866
Losartan Potassium237$1,833

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$278,997374 claims
AstraZenecaFarxiga, Brilinta$405$69,976101 claims
Boehringer IngelheimJardiance$244$65,55696 claims
Johnson & JohnsonXarelto$344$60,86252 claims
NovartisEntresto$254$47,17256 claims
Esperion Therapeutics, Inc.Nexletol$130$5,64214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →